When was iMetabolic Biopharma Corporation founded?

iMetabolic Biopharma Corporation was founded in 2017 and raised its 1st funding round 6 years after it was founded.

Where is iMetabolic Biopharma Corporation located?

iMetabolic Biopharma Corporation is headquartered in Tempe, United States. It is registered at 2155 E Conference Dr , Suite 104, Tempe, AZ.

How many employees does iMetabolic Biopharma Corporation have?

As of Apr 30, 2026, the latest employee count at iMetabolic Biopharma Corporation is 8.

Is iMetabolic Biopharma Corporation a funded company?

iMetabolic Biopharma Corporation is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jul 01, 2023.

When was the latest funding round of iMetabolic Biopharma Corporation?

iMetabolic Biopharma Corporation's latest funding was a $***** Grant (prize money) round on Sep 15, 2024, with participation from 1 investor.

Where does iMetabolic Biopharma Corporation rank among its competitors?

iMetabolic Biopharma Corporation ranks 68th amongst 185 active competitors, of which 19 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was RevolKa, which secured $1.4M in May, 2025.

Who are the top competitors of iMetabolic Biopharma Corporation?

iMetabolic Biopharma Corporation's top competitors include Zephyr AI, Transaction Data Systems and RevolKa. Among them, RevolKa secured the most recent funding round in May, 2025.

iMetabolic Biopharma Corporation - 2026 Company Profile, Funding & Competitors

iMetabolic Biopharma Corporation is a funded company based in Tempe (United States), founded in 2017. It operates as a Provider of software development services to biopharma sector. iMetabolic Biopharma Corporation has raised an undisclosed amount in funding. The company has 185 active competitors, including 19 funded and 19 that have exited. Its top competitors include companies like Zephyr AI, Transaction Data Systems and RevolKa.

Company Details

Website: imbiopharma.com
Registered Address: 2155 E Conference Dr , Suite 104, Tempe, AZ

Key Metrics

Founded Year

2017

Location

Tempe, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Sep 15, 2024, $*****

Investors

HHS

Ranked

68^th among 185 active competitors

Employee Count

8 as on Apr 30, 2026

Similar Companies

Zephyr AI & 212 more

View iMetabolic Biopharma Corporation's full profile

iMetabolic Biopharma Corporation is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
iMetabolic Biopharma Corporation CIN: 0001957114 , United States, Active		$0 - $1M (As on Dec 31, 2023)	4 (As on Dec 31, 2023)	-

iMetabolic Biopharma Corporation has raised funding over 2 rounds. Its first funding round was on Jul 01, 2023. Its latest funding round was a Grant (prize money) round on Sep 15, 2024 for $*****. 1 investor participated in its latest round. iMetabolic Biopharma Corporation has 1 institutional investor.

Here is the list of recent funding rounds of iMetabolic Biopharma Corporation:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 15, 2024	9604997	Grant (prize money)	4080225	1685536	6458561	5465468
Jul 01, 2023	7424436	Grant (prize money)	5532850	9842516	4179064	HHS

Access funding benchmarks and valuations. Sign up today!

View details of iMetabolic Biopharma Corporation's funding rounds and investors

iMetabolic Biopharma Corporation's employee count trend

iMetabolic Biopharma Corporation has 8 employees as of Apr 26. Here is iMetabolic Biopharma Corporation's employee count trend over the years:

Employee count trend for iMetabolic Biopharma Corporation

Uncover iMetabolic Biopharma Corporation's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of iMetabolic Biopharma Corporation include Zephyr AI, Transaction Data Systems and RevolKa. Here is the list of Top 10 competitors of iMetabolic Biopharma Corporation, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Zephyr AI 2020, United States, Series A	Provider of AI development services for biopharma sector	$130M	Revolution, Lilly & 12 others	57/100
2nd	Transaction Data Systems 1977, Earth City (United States), Acquired	Provider of software development services to biopharma sector	-	-	47/100
3rd	RevolKa 2021, Chuo City (Japan), Series A	Provider of AI development services for biopharma sector	$3.1M	D3, DEEPCORE & 3 others	46/100
4th	EDETEK 2009, Princeton (United States), Funding Raised	Provider of digital clinical trial solutions	-	LDV Partners	42/100
5th	Axle Informatics 2002, Bethesda (United States), Unfunded	Provider of software collaboration and laboratory informatics tools for biopharma sector	-	-	39/100
6th	Telescope Innovations 2019, Vancouver (Canada), Public	Develops software platforms for biopharma sector	-	New Age Ventures	38/100
7th	Biogaran 1996, Colombes (France), Unfunded	Provider of software development services for biopharma sector	-	-	38/100
8th	Dash Technologies 2010, Columbus (United States), Unfunded	Provider of software engineering, product engineering, and artificial intelligence development services for healthcare organizations	-	-	37/100
9th	Xavo 2000, Bayreuth (Germany), Unfunded	Provider of software services for biopharma sector	-	-	37/100
10th	bodygram 2003, San Francisco (United States), Funding Raised	Provides body sizing machine	-	Inspire, Social Starts & 2 others	37/100
68th	iMetabolic Biopharma Corporation 2017, Tempe (United States), Funding Raised	Provider of software development services to biopharma sector	-	HHS	22/100